NCT01228552

The Efficacy and Safety of Intra-oral Topical Ketoprofen for the Treatment of Acute Migraine

A Randomized Double Blind, Placebo Controlled Phase III Trial to Determine the Efficacy and Safety of Topical Intra-oral Ketoprofen for the Treatment of Acute Migraine

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Behar, Caren, M.D. · Individual
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of intra-oral topical ketoprofen for the treatment of acute migraine.

Conditions

• Migraine Disorders
• Migraine Headache
• Migraine
• Acute Migraine

Interventions

Type	Name	Description
DRUG	Topical, intra-oral ketoprofen gel	Ketoprofen gel will be applied, using a cotton applicator, to the gingival mucosa at the onset of migraine. A second application may be used at 20 minutes, if necessary.
OTHER	Placebo gel	Placebo gel will be applied, using a cotton applicator, to the gingival mucosa at the onset of migraine. A second application may be used at 20 minutes, if necessary.

Timeline

• Start date: 2011-12-01
• Primary completion: 2012-01-01
• Completion: 2012-01-01
• First posted: 2010-10-26
• Last updated: 2011-06-08

Locations

1 site across 1 country: United States